Latham  Watkins Advises Blackstone Life Sciences on $750 Million R Funding Agreement with Johnson  Johnson
Trendline

Latham Watkins Advises Blackstone Life Sciences on $750 Million R Funding Agreement with Johnson Johnson

What's Happening? Latham & Watkins LLP represented Blackstone Life Sciences in a significant R&D funding agreement. Funds managed by Blackstone Life Sciences will provide US$750 million to Johnson & Johnson. This funding is designated to support the Phase 3 clinical development of OLN324, an investi
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.